Synergistic anti-proliferative effect of mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity

This item is shared privately

dataset

modified on 2018-01-09, 15:44

Tumor volume of different combinations for HuCCT1 (k-ras mutation) and TFK-1 (k-ras wild-type) xenografts.

Keywords